A Single Arm Phase II Study of Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma: Interim Biopsy Analysis to Determine Efficacy. Acronym: NivoMes Study

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 05 Dec 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

01 Nov 2022 Results of an analysis assessing possible impact of subgroups of immune cells in subsequent tumor biopsies of patients treated with ICIs from two clinical studies: NCT02497508 (n=34) and NCT03048474 (n=36) published in the Lung Cancer
17 Nov 2021 Results published in the Journal of Thoracic Oncology
10 Jul 2018 Planned number of patients changed from 33 to 34.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com